Sushant Kharel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sushant Kharel has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Dipanker Prajapati
Department of Cardiology, Shahid Gangalal National Heart Centre, Bansbari, Kathmandu, Nepal
3 shared publications- Birat Krishna Timalsena
Department of Cardiology, Shahid Gangalal National Heart Centre, Bansbari, Kathmandu, Nepal
2 shared publications - Chandra Mani Adhikari
Department of Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
2 shared publications Amrit Bogati
Department of Cardiology Shahid Gangalal National Heart Centre Kathmandu Nepal
1 shared publication- Amrit Bogati
Department of Cardiology, Shahid Gangalal National Heart Centre, Bansbari, Kathmandu, Nepal
1 shared publication Anjana Acharya
Department of Cardiology, Shahid Gangalal National Heart Centre, Kathmandu, Nepal
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Nepal Health Research Council in Journal of Nepal Health Research Council
- Vol. 24 (02) , 190-200
Clinical Presentation, Management and Outcome of Heart Failure Patients
Background: Heart failure is a major public health issue with rising hospitalizations and high mortality. This study was conducted to assess the clinical presentation, management and outcome of heart failure patients presenting to a tertiary care hospital. Methods: A prospective, observational study was conducted at a tertiary cardiac center in Nepal over a period of six months among admitted patients aged 18 years and above with heart failure. Data on demographics, etiology, treatment, and outcomes were collected via structured interviews, chart review, clinical observation, phone calls and follow-up. Etiologies were defined per standard criteria and patients were categorized according to the clinical and echocardiographic diagnosis. Results: Among 1523 patients included, the mean age of the cohort was 61.5 ± 14.9 years, and 62.0 % were male. Coronary artery disease (65.8%) was the most common etiology, followed by idiopathic dilated cardiomyopathy (15.0%) and rheumatic heart disease (7.2%). Acute coronary syndrome (39.9%) was the primary aggravating factor. Guideline-directed medical therapy use included Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker (68.5%), Beta-blockers (66.1%), and Mineralocorticoid Receptor Antagonists (61.2%); however, the use of Sodium-Glucose Cotransporter-2 inhibitors was low (15.2%). Device therapy was rare (0.26%). The overall mortality rate was 12.7%, comprising 4.7% in-hospital mortality and 7.9% 90-day mortality.Conclusions: Coronary artery disease is the commonest etiology, with Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker as the commonest prescription, followed by Beta-blockers and Mineralocorticoid Receptor Antagonists, with device therapy being rare, with an overall mortality of 12.7%. Keywords: Coronary artery disease; dilated cardiomyopathy; guideline-directed medical therapy; heart failure.
- 15 October 2026
- Published by Nepal Health Research Council in Journal of Nepal Health Research Council
- Vol. 24 (02) , 190-200
Open AccessClinical Presentation, Management and Outcome of Heart Failure Patients
Background: Heart failure is a major public health issue with rising hospitalizations and high mortality. This study was conducted to assess the clinical presentation, management and outcome of heart failure patients presenting to a tertiary care hospital. Methods: A prospective, observational study was conducted at a tertiary cardiac center in Nepal over a period of six months among admitted patients aged 18 years and above with heart failure. Data on demographics, etiology, treatment, and outcomes were collected via structured interviews, chart review, clinical observation, phone calls and follow-up. Etiologies were defined per standard criteria and patients were categorized according to the clinical and echocardiographic diagnosis. Results: Among 1523 patients included, the mean age of the cohort was 61.5 ± 14.9 years, and 62.0 % were male. Coronary artery disease (65.8%) was the most common etiology, followed by idiopathic dilated cardiomyopathy (15.0%) and rheumatic heart disease (7.2%). Acute coronary syndrome (39.9%) was the primary aggravating factor. Guideline-directed medical therapy use included Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker (68.5%), Beta-blockers (66.1%), and Mineralocorticoid Receptor Antagonists (61.2%); however, the use of Sodium-Glucose Cotransporter-2 inhibitors was low (15.2%). Device therapy was rare (0.26%). The overall mortality rate was 12.7%, comprising 4.7% in-hospital mortality and 7.9% 90-day mortality.Conclusions: Coronary artery disease is the commonest etiology, with Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker as the commonest prescription, followed by Beta-blockers and Mineralocorticoid Receptor Antagonists, with device therapy being rare, with an overall mortality of 12.7%. Keywords: Coronary artery disease; dilated cardiomyopathy; guideline-directed medical therapy; heart failure.
- Open Access
- 21 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 3 (2) , 140-144
ASD Device Closure in Dextrocardia with Situs Inversus Totalis
Device closure of the atrial septal defect in dextrocardia with situs inversus totalis has been reported previously. Dextrocardia with situs Inversus totalis in ASD makes the procedure complex.With proper imaging ASD device closure can be done in such cases. We present a case of a 19 years old female, who underwent successful ASD device closure for the second time in our center.
- 21 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 3 (2) , 140-144
Open AccessASD Device Closure in Dextrocardia with Situs Inversus Totalis
Device closure of the atrial septal defect in dextrocardia with situs inversus totalis has been reported previously. Dextrocardia with situs Inversus totalis in ASD makes the procedure complex.With proper imaging ASD device closure can be done in such cases. We present a case of a 19 years old female, who underwent successful ASD device closure for the second time in our center.
- Open Access
- 31 May 2024
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 21 (1) , 43-48
Accuracy of Electrocardiography Criteria for Left Ventricular Hypertrophy in Hypertensive Patients at Shahid Gangalal National Heart Centre
Background: Hypertension is the leading cause of cardiovascular disease and premature death worldwide. Left ventricular hypertrophy (LVH), a measure of hypertensive target organ damage in the heart is associated with increased morbidity, mortality and development of arrhythmias. This study was designed to identify the more accurate ECG criteria for identifying LVH taking LVH by echocardiography as reference. Methods: A cross sectional study was conducted at Shahid Gangalal National Heart Centre. A total of 252 patients were included. A 12-lead ECG and Echocardiography were done. Analysis done by SPSS 25. Stata-14 software was used for ROC (Receiver operating characteristics) comparison and P<0.05 considered statistically significant. Results: Sensitivity, specificity, PPV, NPV and accuracy of Sokolow-Lyon criteria in diagnosis LVH was 41.8%, 80.8%, 67.1%, 59.7% and 61.9% respectively. The results of the test parameters taking Cornell Voltage criteria to detect LVH was 65.6%, 73.1%, 69.6% 69.3% and 69.4%. Likewise, the test parameters of cornell voltage duration measurement was 57.4%, 84.6%, 77.8%, 67.9% and 71.4% respectively. Similarly results of the test parameters by Romhilt-Estes system was 36.9%, 88.5%, 75%, 59.9% and 63.5% respectively. Area under the curve (AUC) of Sokolow-Lyon index, Cornell voltage criteria, Cornell voltage duration measurement and Romhilt- Estes system was 0.613, 0.693, 0.71 and 0.627 respectively. Conclusion: In our study Cornell Voltage duration measurement criteria had a higher sensitivity and higher AUC to detect LVH. The different ECG criteria must be integrated with the clinical scenario. Isolated interpretation of LVH using a single ECG criteria has a low diagnostic value
- 31 May 2024
- Published by Nepal Journals Online (JOL) in Nepalese Heart Journal
- Vol. 21 (1) , 43-48
Open AccessAccuracy of Electrocardiography Criteria for Left Ventricular Hypertrophy in Hypertensive Patients at Shahid Gangalal National Heart Centre
Background: Hypertension is the leading cause of cardiovascular disease and premature death worldwide. Left ventricular hypertrophy (LVH), a measure of hypertensive target organ damage in the heart is associated with increased morbidity, mortality and development of arrhythmias. This study was designed to identify the more accurate ECG criteria for identifying LVH taking LVH by echocardiography as reference. Methods: A cross sectional study was conducted at Shahid Gangalal National Heart Centre. A total of 252 patients were included. A 12-lead ECG and Echocardiography were done. Analysis done by SPSS 25. Stata-14 software was used for ROC (Receiver operating characteristics) comparison and P<0.05 considered statistically significant. Results: Sensitivity, specificity, PPV, NPV and accuracy of Sokolow-Lyon criteria in diagnosis LVH was 41.8%, 80.8%, 67.1%, 59.7% and 61.9% respectively. The results of the test parameters taking Cornell Voltage criteria to detect LVH was 65.6%, 73.1%, 69.6% 69.3% and 69.4%. Likewise, the test parameters of cornell voltage duration measurement was 57.4%, 84.6%, 77.8%, 67.9% and 71.4% respectively. Similarly results of the test parameters by Romhilt-Estes system was 36.9%, 88.5%, 75%, 59.9% and 63.5% respectively. Area under the curve (AUC) of Sokolow-Lyon index, Cornell voltage criteria, Cornell voltage duration measurement and Romhilt- Estes system was 0.613, 0.693, 0.71 and 0.627 respectively. Conclusion: In our study Cornell Voltage duration measurement criteria had a higher sensitivity and higher AUC to detect LVH. The different ECG criteria must be integrated with the clinical scenario. Isolated interpretation of LVH using a single ECG criteria has a low diagnostic value
- Open Access
- 25 January 2024
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 3
Prevalence and Spectrum of Iron Deficiency in Heart Failure Patients in a Tertiary Cardiac Centre in Nepal
Background: Iron deficiency (ID) is a major heart failure comorbidity associated with increased mortality, worse symptoms and a poorer quality of life, irrespective of anaemia. In Nepal, limited data are available to permit an estimation of the spectrum and prevalence of ID associated with heart failure, which the present study aimed to find. Methods: A single-centre, cross-sectional, observational study was conducted at a tertiary care hospital in Kathmandu, Nepal. Patients meeting validated clinical criteria of heart failure were included and assessed for their iron status. Absolute ID was defined as serum ferritin <100 μg/l and functional ID was defined as normal ferritin (100–300 μg/l), with low transferrin saturation <20%. Data were analysed using SPSS (version 23). A logistic regression model was used to calculate the OR, with p-values 65 years (OR 1.97; 95% CI [1.21–3.21]) and anaemia (OR 7.01; 95% CI [4.08–12.06]) were significantly associated with ID. ID without anaemia was present in 29% of patients. Conclusion: The present study showed a high prevalence of ID in heart failure patients, which was significantly associated with older age, female sex and higher New York Heart Association class. It also showed that a significant number of patients who were non-anaemic had ID. Therefore, iron profiling and treatment should be a part of the routine assessment of patients with heart failure.
- 25 January 2024
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
- Vol. 3
Open AccessPrevalence and Spectrum of Iron Deficiency in Heart Failure Patients in a Tertiary Cardiac Centre in Nepal
Background: Iron deficiency (ID) is a major heart failure comorbidity associated with increased mortality, worse symptoms and a poorer quality of life, irrespective of anaemia. In Nepal, limited data are available to permit an estimation of the spectrum and prevalence of ID associated with heart failure, which the present study aimed to find. Methods: A single-centre, cross-sectional, observational study was conducted at a tertiary care hospital in Kathmandu, Nepal. Patients meeting validated clinical criteria of heart failure were included and assessed for their iron status. Absolute ID was defined as serum ferritin <100 μg/l and functional ID was defined as normal ferritin (100–300 μg/l), with low transferrin saturation <20%. Data were analysed using SPSS (version 23). A logistic regression model was used to calculate the OR, with p-values 65 years (OR 1.97; 95% CI [1.21–3.21]) and anaemia (OR 7.01; 95% CI [4.08–12.06]) were significantly associated with ID. ID without anaemia was present in 29% of patients. Conclusion: The present study showed a high prevalence of ID in heart failure patients, which was significantly associated with older age, female sex and higher New York Heart Association class. It also showed that a significant number of patients who were non-anaemic had ID. Therefore, iron profiling and treatment should be a part of the routine assessment of patients with heart failure.